Individual Health Plans


 Individual Health Plans Affordable Health Insurance
Fantasy Aces: Match game

He's currently No. 3 in the world, and started this season with a runner-up finish at the the Mercedes-Benz Championship, a tie for fourth at the Sony Open and a tie for 11th last week in L.A.

Go ahead, point out the fact that he lost the Mercedes to Daniel Chopra in a sudden-death playoff, which can be considered a match-play situation.

But here's the best part: Stricker faces Chopra in Wednesday's first round.

He will get his revenge.

Ace up Soderstrom's sleeve: Scott Verplank.

Picking a guy who's known for stepping it up in Ryder Cups and Presidents Cups doesn't seem like a bad choice, until you see who he's up against in Round 1: Tiger-killer Nick O'Hern. I still like the upset here.


Lance Ringler's best bet: K.J.


Arura Pharma Inc. announces strategic re-focusing to unlocking ...

MONTREAL, Feb. 19 /CNW Telbec/ - Arura Pharma Inc. (TSXV: ARP) ("Arura") is pleased to announce that its Board of directors has authorised a strategic re-organisation of Arura's commercial activities in order to unlock value for its shareholders. Arura will now mainly focus on its established manufacturing and distribution of consumer health products unit in health, personal hygiene and beauty aids while keeping a separate economic interest in the promising Speciality Pharma business unit.

As part of this exercise, Mr. Daniel Pharand, current chairman of the Board of directors of Arura, has accepted to take on the function of Executive Chairman, while Mr. Ali Moghaddam has accepted to terminate his functions of Chief Executive Officer and director of Arura effective immediately in order to perform a successful spin-off of the speciality pharma activities of Arura.


kf Feels Brad Grey's Pain!

For example, the government could undoubtedly use its monopsony power to lower the price it pays for drugs--maybe lower the price to something approaching the marginal cost of producing additional pills. It's not at all clear, however, that this is the price we should want to pay, because it does little to fund research and development costs of developing both the existing drug and new drugs. See Michael Kinsley's analysis here. Paying medical providers enough to fund future advances will be very expensive.

4) Yglesias writes

The significant financial challenge has to do with covering the bills for old people, but that challenge exists one way or another thanks to Medicare (and the basic reality that senior citizens are largely uninsurable in the private sector) and has relatively little to do with whether or not we can afford to bring universal coverage to the under-65 crowd.


Junk Science: Mayor Gloomberg

After speaking at a United Nations meeting on global warming, Bloomberg told reporters, "Terrorists kill people. Weapons of mass destruction have the potential to kill an enormous amount of people, but global warming in the long term has the potential to kill everybody."

He continued, "We should go after terrorists every place in this world, find them and kill them, plain and simple. [If weapons of mass destruction] get out of the hands of the countries that have them and get into the hands of terrorists, the potential is just mind-boggling … [and while global warming] is a much longer-term thing … [it] has all of the same potentials of destroying the planet that we live on.

"No scientist knows for sure what's going to happen, but you don't want to wait to find out."

While we easily could write-off Bloomberg's comments as simply inane hyperbole, they're really quite irresponsible for a public official to make as they're not based on any sort of scientific reality — even in the weird reference frame of standard climate hysteria.


Soldiers’ Accounts

Thrown against the wall and so forth.

He was very frustrated with this person, who supposedly had information about the whereabouts of Zarqawi. And he did. But we didn’t know exactly that. He was blatantly stalling us and lying to us. It was frustrating, but he [the British soldier] decided to go that route and get physical with him. . . . [W]e ended up cutting in. “This is not working, we need to stop this.”. . . I took the prisoner back and my partner took the other guy. It was reported. They weren’t upset about any type of abuse or anything. They were just upset that he [the British soldier] was interrogating anybody at all, because it was not in adherence with the rules. Because he wasn’t American or he wasn’t, you know, signed on to do that type of job. He was allowed to stick around, but he wasn’t allowed to talk to any more detainees.


The top 50 greatest covers as voted by you

15px; margin-bottom: 15px; } /* for enclosing the MPU ad */ hr.mpu { background:#FFF; border: 1px dotted gray; border-top:0; color: #FFFFFF; } #mpu_ie_hack { text-align: center; } #spacedesc_mpu_iframe { margin-left: auto; text-align: left; margin: 1em auto; width: 300px; } div.mpu_continue { text-align: right; } a.mpu_continue:link {text-decoration: none; color: gray;} a.mpu_continue:visited {text-decoration: none; color: gray;} a.mpu_continue:hover {text-decoration: none; color: gray;} a.mpu_continue:active {text-decoration: none; color: gray;} img.mpu_continue { padding: 1px; } .


Hot Stove: Wilkerson to Seattle

Apparently, the Mariners grew tired of waiting. Only days after the team was rumored to sign Brad Wilkerson contingent on them trading right fielder Adam Jones to the Orioles in the Erik Bedard deal, they decided to proceed regardless. Wilkerson hopped aboard, Jones or not, for a one-year, $3 million contract.

Whether this means there's hope the Bedard deal will be concluded in the next several days is unclear, but consider Wilkerson's addition a promising sign. Even if talks fall through, though, and Jones remains in Seattle, Wilkerson can provide adequate insurance against the team's somewhat questionable alternatives at designated hitter and/or first base.

.


New vaccinations give scientists hope of conquering flu pandemic

A vaccine that could help to control a flu pandemic has shown encouraging results in its first human trials.

The vaccine, made by Acambis, based in Cambridge, should protect against all strains of influenza A, the type responsible for pandemics. Unlike existing vaccines it does not have to be reformulated each year to match the prevalent strains of flu, so it could be stockpiled and used as soon as a pandemic strain emerges. Nor does it need to be grown on fertilised chicken eggs, as the existing vaccines do, but can be produced by cell culture.

The results, announced yesterday by Acambis, show that in human volunteers the Acam-Flu-A vaccine was safe and produced an immune response against its target, a small protein (peptide) called M2e that is found on the surface of all A-strains of the flu virus.


July 2007

We aggregate stories about Cape Cod and Islands from all media & collect them here for you. You are invited to comment on any story. Your opinion will appear on our front page immediately, and it will be archived and available on this site at any time at no charge by using the search element of the top of every page. Last comments .


 
Link to us - Contact us